Courses
| COST: FREE |
Universal Program Number: 0048-0000-12-049-H01-P
Expires: August 4, 2015
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Unintended pregnancies are a common occurrence in the United States. According to the most recent data available, 3.2 million unintended pregnancies occurred in the U.S. during 2006, which is roughly half of all pregnancies.1 Ongoing contraceptive methods are effective in significantly reducing unintended pregnancies. However, there are an estimated 4.5 million women at risk for pregnancy that do not use a regular method of contraception.1 The dispensing of emergency contraception can be used as an opportunity to introduce patients to other long-term contraceptive techniques while effectively preventing pregnancy when it was not their specific plan to have a child. Table 1 highlights therapeutic options currently available in the United States for emergency contraception. Levonorgestrel is one potential option for utilization as emergency contraception with documented efficacy and unique availability in pharmacies as a behind-the-counter product without a prescription for certain patient populations.
Universal Program Number: 0048-0000-12-081-H01-P
EXPIRES: October 9, 2015
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description: It is estimated that about 400,000 people in the United States are living with MS.1 The disease most commonly effects people in Europe, the United States, Canada, Australia, and New Zealand. It appears as though incidence and prevalence increase the farther you get from the Equator. Women tend to be affected 1.5-2.5 times more than men. Peak onset in patients is usually between the ages of 25 and 35, with a sharp increase after adolescence and a shallow decline after the peak age. Genetics play a strong role in multiple sclerosis. It is estimated that one’s risk for MS is 30 times higher if you have a sibling with MS.2 Other environmental factors are thought to contribute include sunlight exposure, infections, vaccines, tobacco, nutrition, and xenobiotics, but no association has been confirmed.2,3
Universal Program Number: 0048-0000-12-080-H04-P
EXPIRES: October 9, 2015
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description: Prescription stimulants such as dextroamphetamine/amphetamine combination (Adderall®), methylphenidate (Concerta®), and lisdexamfetamine (Vyvanse®) are schedule II medications and are the most commonly prescribed drugs to children and adults for the treatment of attention deficit hyperactivity disorder (ADHD). ADHD is one of the most common childhood disorders and can continue into adolescence and even into adulthood. The common symptoms include difficulty staying focused and paying attention, difficulty controlling behavior, and over activity. Symptoms usually improve as the patient grows older. It is estimated that about 8 percent of children 4-17 years old are diagnosed with ADHD. 1 These drugs are very effective in the treatment of ADHD but also have the potential for both abuse and addiction.
Universal Program Number: 0048-0000-12-079-H01-P
EXPIRES: October 9, 2015
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description: The substance 3,4-methylenedioxymethamphetamine is commonly known as MDMA. MDMA has many names and can be referred to as: ecstasy, E, X, XTC, Rolls, Beans, Adam, or Molly. MDMA is popular with young people involved in the dance culture.1 MDMA tablets are commonly known to be impure and often mixed with other drugs of abuse. Although MDMA is not a prescription drug, it is important for pharmacists to be aware of this substance because it has many adverse effects that may require medical management.
Universal Program Number: 0048-0000-12-078-H04-P
EXPIRES: October 9, 2015
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description: Several over-the counter-medications are commonly used for unintended recreational purposes or as ingredients for illicit drugs. Over the years, many restrictions have been placed on the purchase of these medications, but there are always those who seek to find a way around these regulations. As a pharmacist, you are the medication gatekeeper of the community and the responsibility falls on you to prevent the abuse of medication in order to protect your patients. This lesson will be broken down by individual medications in order to go into more depth.
Universal Program Number: 0048-0000-12-077-H01-P
EXPIRES: October 9, 2015
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description: The following is a comprehensive summary of the individual guidelines provided by the American Association of Clinical Endocrinologists (AACE), the American Diabetes Association (ADA), and the American Geriatrics Society (AGS). The summary will focus on the ADA guidelines and highlight specific differences between the other organizations’ guidelines. In addition, recommendations will be made to help guide pharmacists to the most appropriate guidelines to use for a specific patient. Information designated by orange boxes denotes a difference in recommendations by the AACE. Information in blue boxes emphasizes a difference in recommendations by the AGS.
Universal Program Number: 0048-0000-12-076-H01-P
EXPIRES: October 9, 2015
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description: Current categories for compounds of abuse in the United States include alcohol, tobacco, opioids, club drugs, cannabinoids, stimulants, dissociative drugs, hallucinogens, anabolic steroids, inhalants and prescription medications. Heroin, also known as smack, H, skag, or junk, falls into the category of opioids and is the most abused drug in this category.1 This is because it is rapid acting with a time to peak plasma absorption of 10 minutes after I.M. administration and it crosses the blood brain barrier faster than morphine, the drug heroin is manufactured from.2 Morphine is produced by the seed pods of the poppy plant and then sold in a pure form or sometimes mixed/“cut” with substances such as sugar, quinine, powdered milk or even some poisons to produce street heroin.1
Universal Program Number: 0048-0000-12-075-H01-P
EXPIRES: October 9, 2015
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description: Addiction is a growing problem in society as more people experiment with illicit drugs and fall into drug addiction as a consequence. Addicts tend to exhibit symptoms of drug tolerance with continued abuse and may develop substance dependence. As one continues to use a drug to achieve a “rush” or a “high”, some must use increasing amounts of a given drug to achieve the same high that was experienced previously, depending on the substance used. Many addicts continue to increase doses until drug-induced overdose or death occurs. Addicts are also fueled by the desire to avoid withdrawal symptoms, which may range from nausea and resting tremors to anxiety and insomnia1. If the search for drugs interferes with daily living, this is called substance dependence, as one plans time and resources around acquiring the next hit of drug.
Universal Program Number: 0048-0000-10-019-H01-P
EXPIRES: March 12, 2013
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description:Despite advancement in treatment methods, cardiovascular disease (CVD) remains the leading cause of death in the United States.1 While debate lingers about the utilization of non-traditional risk factors and risk markers for cardiovascular disease, appropriate management utilizing the current standard of care can greatly reduce the risk of CVD. As pharmacists we play a major role by offering therapeutic recommendations based on current guidelines and appropriate education about emerging risk markers. To be an effective clinician, it is important to understand what constitutes a cardiac risk factor and the general pathophysiology of cholesterol homeostasis. The objective of this article is to establish effective management of dyslipidemia while assessing future trends in patient care.
Fall 2010 Ampule - If you've submitted a hardcopy quiz, credit can only issued once.
Universal Program Number: 0048-0000-10-039-H01-P
EXPIRES: September 16, 2013
Program Length: 0.1 CEU
Target Audience: Pharmacists
Knowledge based activity
Description: Obesity is a growing epidemic in the United States and is associated with significant morbidity and mortality. Traditional treatments, including lifestyle changes and pharmacological treatments, are generally ineffective. Bariatric surgery offers an effective treatment for obesity in certain patients, producing significant, long-term weight loss and reduction in the complications associated with obesity, including improvements in concurrent disease states and life expectancy.
· This course has expired. If you need a copy of your certificate, please contact site administrator.
This course has expired. If you need a copy of your certificate, please contact site administrator.
Important:
If you DO NOT receive a confirmation email to access this site, email the site administrator.
Don't forget to fill out the survey! They are required to receive certificate.
Your certificate will issue with your site registration name. Using an alternate name may invalidate your certificate.